Semaglutide works by stimulating insulin release when blood glucose levels are elevated, reducing glucagon secretion, and slowing gastric emptying
Focus on fat deposits that are difficult to reduce through diet and exercise alone
These treatments not only support meaningful weight loss but also help improve overall health markers like blood sugar, blood pressure, and energy levels
Patients may increase exercise intensity or duration as they lose weight and gain confidence, potentially leading to overuse injuries or delayed-onset muscle soreness that may be perceived as joint pain
That suggests Novo Nordisk agreed to entry date for the generics before June 2033, i.e., the expiration date of the 462 patent
95% CI: 0.55-0.92 in patients without baseline SGLT2 inhibitor use and HR: 0.34